GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Libra Infusions Ltd (DHA:LIBRAINFU) » Definitions » Debt-to-Revenue
中文

Libra Infusions (DHA:LIBRAINFU) Debt-to-Revenue

: 0.00 (As of . 20)
View and export this data going back to . Start your Free Trial

Debt-to-Revenue measures a company's ability to pay off its debt.

Libra Infusions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Libra Infusions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. Libra Infusions's annualized Revenue for the quarter that ended in . 20 was BDT0.00 Mil.


Libra Infusions Debt-to-Revenue Historical Data

The historical data trend for Libra Infusions's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Libra Infusions Annual Data
Trend
Debt-to-Revenue

Libra Infusions Semi-Annual Data
Debt-to-Revenue

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Libra Infusions's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Libra Infusions Debt-to-Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Libra Infusions's Debt-to-Revenue falls into.



Libra Infusions Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Libra Infusions's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Libra Infusions's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Libra Infusions Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Libra Infusions's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Libra Infusions (DHA:LIBRAINFU) Business Description

Traded in Other Exchanges
N/A
Address
I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.

Libra Infusions (DHA:LIBRAINFU) Headlines

No Headlines